- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting tumor-associated macrophages for cancer immunotherapy
Authors
Keywords
Tumor, Immunotherapy, Tumor-associated macrophages (TAMs)
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1874, Issue 2, Pages 188434
Publisher
Elsevier BV
Online
2020-09-18
DOI
10.1016/j.bbcan.2020.188434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model
- (2019) Fatemeh Tahmasebi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
- (2019) Shu Lian et al. EBioMedicine
- Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
- (2019) Camilla Salvagno et al. NATURE CELL BIOLOGY
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Emactuzumab Single Agent or in Combination with Paclitaxel in Patients with Advanced/Metastatic Solid Tumors Reveals Depletion of Immunosuppressive M2-like Macrophages
- (2019) C A Gomez-Roca et al. ANNALS OF ONCOLOGY
- CCL2/CCR2 Axis Promotes the Progression of Salivary Adenoid Cystic Carcinoma via Recruiting and Reprogramming the Tumor-Associated Macrophages
- (2019) Zihui Yang et al. Frontiers in Oncology
- Cellular therapy: Immune‐related complications
- (2019) Joseph H. Oved et al. IMMUNOLOGICAL REVIEWS
- Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
- (2019) Magdalena Jarosz-Biej et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages
- (2019) Yang Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia
- (2019) C.K. Brierley et al. TRANSFUSION
- SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
- (2019) Ya-Ping Chen et al. Blood Cancer Journal
- Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples
- (2019) Eleanor M. Scott et al. Journal for ImmunoTherapy of Cancer
- 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment
- (2018) Sofia P. Rebelo et al. BIOMATERIALS
- The role of STAT3 in leading the crosstalk between human cancers and the immune system
- (2018) Yu Wang et al. CANCER LETTERS
- Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
- (2018) Remi Adelaiye-Ogala et al. CANCER RESEARCH
- Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers
- (2018) Sara Nikoofal-Sahlabadi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Implications of macrophage polarization in autoimmunity
- (2018) Samanta C. Funes et al. IMMUNOLOGY
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
- (2018) André Veillette et al. TRENDS IN IMMUNOLOGY
- Chimeric antigen receptors that trigger phagocytosis
- (2018) Meghan A Morrissey et al. eLife
- Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
- (2018) Eric Hatterer et al. mAbs
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia
- (2017) Jun Liu et al. Immunotherapy
- Bone Mass Is Compromised by the Chemotherapeutic Trabectedin in Association With Effects on Osteoblasts and Macrophage Efferocytosis
- (2017) Benjamin P Sinder et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Targeting hepatic macrophages to treat liver diseases
- (2017) Frank Tacke JOURNAL OF HEPATOLOGY
- Macrophages as Key Drivers of Cancer Progression and Metastasis
- (2017) Sebastian R. Nielsen et al. MEDIATORS OF INFLAMMATION
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- (2017) Nan Guo Ring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PSGL-1: A New Player in the Immune Checkpoint Landscape
- (2017) Roberto Tinoco et al. TRENDS IN IMMUNOLOGY
- Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models
- (2017) Melinda Mata et al. Cancer Discovery
- Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
- (2017) Karla R. Wiehagen et al. Cancer Immunology Research
- CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
- (2017) Peter E. van Bommel et al. OncoImmunology
- Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model
- (2016) Chenran Zhang et al. BIOMATERIALS
- Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
- (2016) Mathias Wenes et al. Cell Metabolism
- Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
- (2016) Daniela F. Quail et al. CLINICAL CANCER RESEARCH
- TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
- (2016) Penka S. Petrova et al. CLINICAL CANCER RESEARCH
- STAT3 signaling in immunity
- (2016) Emily J. Hillmer et al. CYTOKINE & GROWTH FACTOR REVIEWS
- PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion
- (2016) Roberto Tinoco et al. IMMUNITY
- CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
- (2016) Vinit Kumar et al. IMMUNITY
- The molecular mechanisms of TLR-signaling cooperation in cytokine regulation
- (2016) Qian Liu et al. IMMUNOLOGY AND CELL BIOLOGY
- Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions
- (2016) Ryan Ortega et al. International Journal of Nanomedicine
- CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
- (2016) Kipp Weiskopf et al. JOURNAL OF CLINICAL INVESTIGATION
- A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects
- (2016) F. Piaggio et al. JOURNAL OF CONTROLLED RELEASE
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
- (2016) Timothy M Nywening et al. LANCET ONCOLOGY
- Macrophage Susceptibility to Emactuzumab (RG7155) Treatment
- (2016) Leon P. Pradel et al. MOLECULAR CANCER THERAPEUTICS
- Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models
- (2016) Takuhiro Shoji et al. NEURO-ONCOLOGY
- Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
- (2016) Heleen H. Van Acker et al. PHARMACOLOGY & THERAPEUTICS
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas
- (2016) D. F. Quail et al. SCIENCE
- FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer
- (2016) Chiara Caparello et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
- (2016) Anna-Maria Georgoudaki et al. Cell Reports
- Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities
- (2016) Ana Teresa Pinto et al. Scientific Reports
- Murine macrophage response from peritoneal cavity requires signals mediated by chemokine receptor CCR-2 during Staphylococcus aureus infection
- (2015) Ajeya Nandi et al. IMMUNOLOGIC RESEARCH
- CAR T-cell therapy: toxicity and the relevance of preclinical models
- (2015) Milena Kalaitsidou et al. Immunotherapy
- A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells
- (2015) Emily C Piccione et al. mAbs
- Macrophages are critical effectors of antibody therapies for cancer
- (2015) Kipp Weiskopf et al. mAbs
- Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
- (2015) Nicholas Butowski et al. NEURO-ONCOLOGY
- Contribution of metabolic reprogramming to macrophage plasticity and function
- (2015) Karim C. EL Kasmi et al. SEMINARS IN IMMUNOLOGY
- CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment
- (2015) Qian-Qian Zhang et al. Scientific Reports
- Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature
- (2015) Daniele Minardi et al. Current Urology Reports
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs
- (2014) P. P. Patwardhan et al. CLINICAL CANCER RESEARCH
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Cellular Metabolism and Macrophage Functional Polarization
- (2014) Linnan Zhu et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Role of Spleen-Derived Monocytes/Macrophages in Acute Ischemic Brain Injury
- (2014) Eunhee Kim et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile
- (2014) E. Sierra-Filardi et al. JOURNAL OF IMMUNOLOGY
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
- (2014) Elisa Gomez Perdiguero et al. NATURE
- CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+T cells
- (2014) Debbie C Strachan et al. OncoImmunology
- Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
- (2014) Turid Hellevik et al. Frontiers in Oncology
- Interleukin-4- and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and Disease
- (2013) Steven J. Van Dyken et al. Annual Review of Immunology
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- In Vitro Evaluation of Inhibitory Effect of Nuclear Factor-KappaB Activity by Small Interfering RNA on Pro-tumor Characteristics of M2-Like Macrophages
- (2013) Yusuke Kono et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
- (2013) J. Xu et al. CANCER RESEARCH
- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
- (2013) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling
- (2013) Christopher James Ferrante et al. INFLAMMATION
- Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer
- (2013) Daniel W. Vermeer et al. INTERNATIONAL JOURNAL OF CANCER
- Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
- (2013) K. Weiskopf et al. SCIENCE
- Thymosin α1 and cancer: action on immune effector and tumor target cells
- (2012) Enrico Garaci et al. Annals of the New York Academy of Sciences
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
- (2012) Simon Yona et al. IMMUNITY
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
- (2012) D Kim et al. LEUKEMIA
- Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia
- (2012) John C. Byrd et al. LEUKEMIA & LYMPHOMA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of CpG ODN on monocytic myeloid derived suppressor cells
- (2012) Hidekazu Shirota et al. OncoImmunology
- Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
- (2011) D. A. Hume et al. BLOOD
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy
- (2011) Zhen Huang et al. JOURNAL OF CONTROLLED RELEASE
- Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma
- (2010) Makoto Iwahashi et al. CANCER SCIENCE
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Alternative Activation of Macrophages: Mechanism and Functions
- (2010) Siamon Gordon et al. IMMUNITY
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β
- (2009) Taku Nagai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy
- (2009) M. Kortylewski et al. CANCER RESEARCH
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
- (2009) F. K. Swirski et al. SCIENCE
- Functions and molecular mechanisms of the CD47–SIRPα signalling pathway
- (2009) Takashi Matozaki et al. TRENDS IN CELL BIOLOGY
- Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40
- (2008) E Oflazoglu et al. BRITISH JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now